1996 April Australian HIV Surveillance Report

Year published: 
1996
1996 April Australian HIV Surveillance Report (pdf)
(84.14 KB)
Description: 

The Australian HIV Surveillance Report has been published on a quarterly basis from July 1990. Reports published from January 1994 are available below. Each report includes article(s) on topics of general interest in the epidemiology of HIV and related infections updates on the number of cases of newly diagnosed HIV infection and AIDS in Australia estimates of HIV incidence and prevalence among people seen through a network of sexual health clinics in Australia.

The Australian HIV Surveillance Update provides a brief summary of HIV and AIDS diagnoses in the most recent quarter, the most recent year and cumulative counts. The Australian HIV Surveillance Update was published separately prior to the July 2000 issue of the Australian HIV Surveillance Report. Updates post April 2000 are included in the Australian HIV Surveilance Report.

Key findings: 
  • Health care workers (HCWS) are potentially at risk of acquiring blood borne viral infections following occupational exposure to blood or body fluid. A national network of hospitals is being established in Australia to measure the extent of occupational exposure to HIV, hepatitis C and hepatitis B in health care workers and the extent of occupationally acquired infection.
  • This first analysis of the surveillance system was based on cases occurring in the six months 1 July to 31 December 1995 and reported on the database by 13 sites—12 hospitals and one community care centre. Three months follow up was available for exposures occurring prior to November 1995.
  • In the 12 hospital sites, the average percutaneous exposure rate was 11.9 per 100 occupied beds and the average non-percutaneous exposure rate was 2.7 per 100 occupied beds.
  • For at least a third of exposures, the source was tested for HIV, hepatitis C or hepatitis B. HIV prevalence was four percent, hepatitis C prevalence was six percent, and hepatitis B e antigen prevalence was 12% among source patients tested following percutaneous exposure by a HCW.

Events